NAD Refers Salonpas Ad Claims To FDA, FTC

By Juan-Carlos Rodriguez (January 21, 2014, 4:29 PM EST) -- The National Advertising Division said Thursday that it's asking the Federal Trade Commission and the U.S. Food and Drug Administration to investigate Hisamitsu America Inc.'s claims regarding the efficacy of its Salonpas pain relief products after the company declined to participate in the NAD's process....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!